| 前收市價 | 5.40 |
| 開市 | 5.59 |
| 買盤 | 5.39 x 200 |
| 賣出價 | 5.45 x 1000 |
| 今日波幅 | 5.34 - 5.91 |
| 52 週波幅 | 1.63 - 8.83 |
| 成交量 | |
| 平均成交量 | 2,374,651 |
| 市值 | 619.246M |
| Beta 值 (5 年，每月) | 1.90 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.92 |
| 業績公佈日 | 2024年8月06日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 6.79 |
Motley FoolBillionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.
Insider MonkeyFate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript May 11, 2024 Fate Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Fate Therapeutics First Quarter 2024 Financial Results Conference Call [Operator Instructions]. This call is […]
ZacksFate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 0% and 140.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
